申请人:——
公开号:US20030087909A1
公开(公告)日:2003-05-08
This invention relates generally to a novel class of fused heterocyclic compounds of the Formula (I) or Formula (II):
1
or pharmaceutically acceptable salt forms thereof, which are inhibitors of trypsin-like serine protease enzymes, especially factor Xa, pharmaceutical compositions containing the same, and methods of using the same as anticoagulant agents for treatment and prevention of thromboembolic disorders.
本发明一般涉及公式(I)或公式(II)的新型融合杂环化合物,或其药学上可接受的盐形式,这些化合物是胰蛋白酶样丝氨酸蛋白酶酶的抑制剂,尤其是因子Xa,包含这些化合物的药物组合物,以及将其用作抗凝剂药物治疗和预防血栓栓塞性疾病的方法。